Nordic Capital related stories
All articles and analysis
Advent in the lead to buy inVentiv for close to $4 billion: ReutersPrivate equity firm Advent International is in advanced talks to acquire inVentiv Group Holdings in a deal that could value the U.S. pharmaceutical research firm at close to $4 billion, including debt, sources told Reuters News.
- Nordic Capital mandates Goldman Sachs for sale of Munters, say sources: Reuters
Swedish buyout group Nordic Capital has started preparations for the sale of Swedish air treatment company Munters in a potential 1 billion euro ($1.10 billion) deal, sources told Reuters.
Private equity firms vie for EQT's Atos Medical, sources say: ReutersA handful of private equity firms have passed to the second round of bidding in an auction for Swedish medical devices firm Atos Medical, which could fetch around 1 billion euros ($1.15 billion), Reuters reported.
- Genstar to sell ERT to Nordic Capital
Genstar Capital agreed to sell ERT, a Philadelphia-based provider of patient data collection solutions for use in clinical drug development, to Nordic Capital. Financial terms of the transaction were not disclosed. Genstar acquired ERT in 2012 for approximately $400 million in a take-private transaction.
Nordic Capital launches sale of Luvata's cooling technology ops: ReutersBuyout group Nordic Capital is launching the sale of its UK-based refrigeration technology and metal components company Luvata, hoping to benefit from still relatively high equity prices, several sources familiar with the matter said.
- Nordic appoints ex-Sandvik CEO as operating partner
The Swedish buyout firm has grown its operations team from one partner to five members as it continues to invest its €3.5bn Fund VIII.
- Cipio Partners sells Cint AB
Cipio Partners said Monday that it sold its portfolio company Cint AB to Nordic Capital. Financial terms weren’t announced. Stockholm-based Cint is a software developer.
- German generics drugmaker Dermapharm put up for sale, say sources: Reuters
Privately-held German generic drugmaker Dermapharm has attracted interest from buyout groups in a potential 1 billion euro ($1.1 billion) deal after being put up for sale by its founder, sources told Reuters.
- Digital River sells Beanstream
Beanstream has been sold to Bambora. Financial terms weren’t announced. Digital River, a Siris Capital portfolio company, was the seller. Beanstream, of Victoria, B.C., provides payment, risk management and authentication solutions to companies and institutions in North America. Buyouts reported news of the sale in May. William Blair advised Beanstream.